Latest news for  (OTC:ISHUF) Stock

OS Therapies reiterates clinical and regulatory path in recurrent, fully respected osteosarcoma with lung metastases, an indication with no currently approved treatments.
 &nbsp;

News

OSTX

OS Therapies Says Phase 2b Clinical Trial Of OST-HER2 Achieves Primary Endpoint With Statistical Significance In Prevention Of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma

Interview

BlackRock CEO Larry Fink Says Don't Believe You'll See BlackRock In The Market Buying Whole Companies

Evercore ISI Group analyst James West downgrades Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) from Outperform to In-Line and lowers the price target from $48 to $39.

Downgrades

Price Target

Analyst Ratings

Evercore ISI Group Downgrades Helmerich & Payne to In-Line, Lowers Price Target to $39

WIIM

Bank of New York Mellon shares are trading higher following better-than-expected Q4 financial results.

SPRC

SciSparc Says It Is Granted 180-Day Extension Until July 14, 2025, By Nasdaq To Regain Compliance With Minimum Bid Requirement

GS: 3% &#x7C; <a href="https://www.benzinga.com//node/42999133">Goldman Sachs Q4 Investment Banking Fees Rose 24% YoY, Global Banking &amp; Markets Revenue Rose 33%, Provision For Credit Losses Fell 39%</a>
&nbsp;
VCEL: -12% &#x7C; <a href="https://www.benzinga.com//node/42997435">Vericel shares are trading lower after the company issued preliminary FY24 and Q4 net revenue below estimates.</a>
&nbsp;
COMP: 11% &#x7C; <a href="https://www.benzinga.com//node/42998131">Compass shares are trading higher after the company raised its Q4 and FY24 guidance.</a>

Movers

Trading Ideas

COMP

VCEL

Market-Moving News for January 15th

AVXL

Anavex Life Sciences Reveals Peer-reviewed Publication Of Oral Blarcamesine Phase IIb/III Data In Journal Of Prevention Of Alzheimer's Disease

Seaport Global analyst Kenneth Zener upgrades KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) from Sell to Neutral.

Upgrades

Seaport Global Upgrades KB Home to Neutral

Prairie expects Average Daily Production: 7,000 – 8,000 barrels of oil equivalent per day (BOEPD), representing a ~300% increase year-over-year.
Prairie plans to actively pursue additional strategic acquisition opportunities, the completion of which will result in an update to guidance to reflect the enhanced scale and value of the Company.

Guidance

PROP

Prairie Operating Expects 2025 Net Income  Of $69M - $102M, Adjusted EBITDA Of $100M - $140M,

Earnings

Goldman Sachs Total Loans Increased 7% During The Year

QBTS

D-wave Quantum Inks Pact With Carahsoft Partner To Expand Distribution Of Quantum Computing Solutions To The Public Sector

Rosenblatt analyst Blair Abernethy maintains Silvaco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVCO#NASDAQ">SVCO</a>) with a Buy and maintains $18 price target.

SVCO

Rosenblatt Maintains Buy on Silvaco Group, Maintains $18 Price Target

ZLAB

Zai Lab Highlights Topline Results For TIVDAK In China Subpopulation Of Global Phase 3 innovaTV 301 Trial In Patients With Recurrent or Metastatic Cervical Cancer

Contracts

STRM

Streamline Health Signs New Contract For Use Of eValuator With Deaconess Health System

Goldman Sachs Q4 Investment Banking Fees Rose 24% YoY, Global Banking & Markets Revenue Rose 33%, Provision For Credit Losses Fell 39%

D. Boral Capital analyst Jesse Sobelson maintains New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) with a Buy and maintains $2 price target.

HOVR

D. Boral Capital Maintains Buy on New Horizon Aircraft, Maintains $2 Price Target

Needham analyst Chris Pierce reiterates TrueCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) with a Buy and maintains $5 price target.

Reiteration

TRUE

Needham Reiterates Buy on TrueCar, Maintains $5 Price Target

D. Boral Capital analyst Jason Kolbert maintains Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) with a Buy and maintains $9 price target.

CNTX

D. Boral Capital Maintains Buy on Context Therapeutics, Maintains $9 Price Target

Goldman Sachs shares are trading higher following better-than-expected Q4 financial results.

XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) has sustained <a href="https://www.benzinga.com/money/ripple-xrp-price-prediction">its bullish momentum</a> for the second consecutive day, driven by speculation around an XRP ETF and increasing whale transactions. 
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.76</td>
<td>$158.5 billion</td>
<td>+7.5%&nbsp;</td>
<td>+19%&nbsp;</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$96,664.83</td>
<td>$1.9 trillion</td>
<td>+0.2%&nbsp;</td>
<td>+1.6%&nbsp;</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$3,197.98</td>
<td>$385.4 billion</td>
<td>-0.5%&nbsp;</td>
<td>-4.5%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Cold Blooded Shiller described XRP as an "alive monster," predicting its ascent to $4.2 if the rally maintains momentum.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The <a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> monster is alive. Pushing against the highs, won&#39;t be long before this breaks and continues it&#39;s ascent upward. $4.20. <a href="https://t.co/srLuW0zF2T">https://t.co/srLuW0zF2T</a> <a href="https://t.co/oOk0X8Jcko">pic.twitter.com/oOk0X8Jcko</a>
&mdash; Cold Blooded Shiller (@ColdBloodShill) <a href="https://twitter.com/ColdBloodShill/status/1879458140808524140?ref_src=twsrc%5Etfw">January 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Satoshi Flipper suggested XRP is on the verge of price discovery, indicating the potential for new highs.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">PRICE DISCOVERY FOR <a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> LOADING <a href="https://t.co/BQXCcZawgW">pic.twitter.com/BQXCcZawgW</a>
&mdash; Satoshi Flipper (@SatoshiFlipper) <a href="https://twitter.com/SatoshiFlipper/status/1879479514813927862?ref_src=twsrc%5Etfw">January 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Statistics: Santiment data highlighted by crypto chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1879457747537670249">shows</a> transactions over $1 million surged to 341 in the last 24 hours.
Coinglass reported XRP futures open interest reached $6 billion (as of Jan. 15), marking an 18% daily increase, the highest since December.
Derivatives trading volume rose 25%, while XRP spot inflows hit $99.3 million, a record high since Dec. 1, 2024.
Community News: David Gokhshtein, founder of Gokhshtein Media, <a href="https://x.com/davidgokhshtein/status/1879352526119850390">acknowledged</a> the rally, stating XRP holders "deserve" this momentum.
Omni Foundation co-founder Austin King <a href="https://x.com/0xASK/status/1879364677316321362">shared</a> insights into Ripple&#8217;s broader vision, beyond the anticipated XRP ETF launch in 2025:
<ul>
<li>Ripple plans to expand its fast, low-cost payment solutions to attract customers from traditional finance.</li>
<li>The company has processed over $50 billion in payments and aims to position the XRP Ledger as the hub for tokenizing global financial assets.</li>
</ul>
Jan. 15 marks the SEC's deadline to file an opening brief in its appeal against Judge Torres' ruling. 
Speculation remains over whether the SEC will contest XRP's classification as a security in programmatic sales.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42985959/xrp-up-16-in-7-days-could-it-temporarily-flip-ethereum-or-even-bitcoin">XRP Up 16% In 7 Days: Could It Temporarily Flip Ethereum Or Even Bitcoin?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

XRP Price Surges Another 7.5%: What Is Going On?

iShares Treasury Bond 0-1yr UCITS ETF USD Accumulation

Comments

News

Latest news for (OTC:ISHUF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga